| scholarly article | Q13442814 |
| P2093 | author name string | Chun-Chao Chang | |
| Shung-Haur Yang | |||
| Chi-Jung Huang | |||
| Chi-Cheng Huang | |||
| Chia-Long Lee | |||
| Chih-Cheng Chien | |||
| Ruey-Neng Yang | |||
| P2860 | cites work | The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes | Q24290792 |
| Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis | Q24616985 | ||
| The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer | Q27004958 | ||
| Genetic alterations during colorectal-tumor development | Q28281200 | ||
| Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression | Q28286300 | ||
| qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data | Q29616810 | ||
| Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy | Q33591943 | ||
| Biomolecular markers as determinants of patients selection for adjuvant chemotherapy of sporadic colorectal cancers | Q33671964 | ||
| Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer | Q33708153 | ||
| G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells | Q33901671 | ||
| Lactoferrin deficiency promotes colitis-associated colorectal dysplasia in mice | Q33946055 | ||
| Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening | Q34247210 | ||
| Cancer genetics and epigenetics: two sides of the same coin? | Q34287662 | ||
| Ketone body utilization drives tumor growth and metastasis | Q34307146 | ||
| Defining new criteria for selection of cell-based intestinal models using publicly available databases. | Q34314896 | ||
| p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs. | Q34434324 | ||
| Identification of a metastasis-specific MicroRNA signature in human colorectal cancer | Q34461847 | ||
| Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes | Q34665492 | ||
| Ribosomal protein S27-like in colorectal cancer: a candidate for predicting prognoses | Q34796352 | ||
| Potential of faecal RNA in diagnosing colorectal cancer. | Q53667246 | ||
| Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer. | Q54280357 | ||
| Upregulation of Fecal Cytokeratin 19 Is Associated with Prognosis in Older Colorectal Cancer Patients | Q54410429 | ||
| A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer | Q59033573 | ||
| Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: association with clinicopathological parameters | Q79937025 | ||
| Mass colorectal cancer screening: methodological quality of practice guidelines is not related to their content validity | Q80564590 | ||
| MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer | Q82931495 | ||
| The solute carrier family 15A4 regulates TLR9 and NOD1 functions in the innate immune system and promotes colitis in mice | Q83323876 | ||
| Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening | Q84022160 | ||
| Heterogeneity of colorectal cancers and extraction of discriminator gene signatures for personalized prediction of prognosis | Q84437197 | ||
| Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer | Q35138892 | ||
| Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression | Q35545627 | ||
| Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression | Q35568362 | ||
| Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer | Q35862470 | ||
| Risk factors for peritoneal dissemination of colorectal cancer | Q35873451 | ||
| Chronic neutrophilic leukemia with overexpression of EVI-1, and concurrent CSF3R and SETBP1 mutations: A case report | Q35944494 | ||
| A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients | Q36109706 | ||
| CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression | Q36673977 | ||
| Colorectal cancer: a multipathway disease | Q36787380 | ||
| Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells | Q36945067 | ||
| DNA/RNA markers for colorectal cancer risk in preserved stool specimens: a pilot study | Q37064970 | ||
| Noninvasive molecular biomarkers for the detection of colorectal cancer | Q37311403 | ||
| Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy | Q37419497 | ||
| Worldwide variations in colorectal cancer | Q37629430 | ||
| Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer | Q37726627 | ||
| Colon cancer screening: which non-invasive filter tests? | Q37959216 | ||
| Advances in the understanding and treatment of colorectal cancer | Q37962733 | ||
| Use of RNA isolated from feces as a promising tool for the early detection of colorectal cancer | Q37994643 | ||
| Novel molecular screening approaches in colorectal cancer | Q37996355 | ||
| Gene expression profiling to dissect the complexity of cancer biology: pitfalls and promise | Q37998270 | ||
| microRNAs in cancer management. | Q38015027 | ||
| Tests and investigations for colorectal cancer screening | Q38207418 | ||
| Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis | Q38232753 | ||
| Biomarkers of colorectal cancer: recent advances and future challenges | Q38259770 | ||
| Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma | Q38399502 | ||
| Surveillance colonoscopy after endoscopic treatment for colorectal neoplasia: From the standpoint of the Asia-Pacific region | Q38727848 | ||
| Apoptosis suppression by candidate oncogene PLAC8 is reversed in other cell types | Q39291594 | ||
| Antitumor activities of synthetic and natural stilbenes through antiangiogenic action | Q39915169 | ||
| Angiocidin inhibitory peptides decrease tumor burden in a murine colon cancer model | Q40089652 | ||
| A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer. | Q40307126 | ||
| Growth-inhibitory effects of the ketone body, monoacetoacetin, on human gastric cancer cells with succinyl-CoA: 3-oxoacid CoA-transferase (SCOT) deficiency | Q40522316 | ||
| Gene expression analysis in colorectal cancer using practical DNA array filter | Q40721746 | ||
| The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production | Q41733077 | ||
| Fecal Tests: From Blood to Molecular Markers | Q42027453 | ||
| Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer | Q44449110 | ||
| The functional evaluation of human peptide/histidine transporter 1 (hPHT1) in transiently transfected COS-7 cells. | Q46805307 | ||
| Upregulation of the growth arrest-specific-2 in recurrent colorectal cancers, and its susceptibility to chemotherapy in a model cell system | Q48057953 | ||
| Multitarget stool DNA testing for colorectal-cancer screening | Q48331668 | ||
| Fecal RNA detection of cytokeratin 19 and ribosomal protein L19 for colorectal cancer | Q48974449 | ||
| P433 | issue | 5 | |
| P921 | main subject | feces | Q496 |
| colorectal cancer | Q188874 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 3378-3384 | |
| P577 | publication date | 2016-08-31 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Discovery of genes from feces correlated with colorectal cancer progression | |
| P478 | volume | 12 |
| Q58729995 | Comprehensive analysis of metastasis-related genes reveals a gene signature predicting the survival of colon cancer patients |
| Q92891477 | Expression pattern of placenta specific 8 and keratin 20 in different types of gastrointestinal cancer |
| Q92758650 | Gut butyrate-producing organisms correlate to Placenta Specific 8 protein: Importance to colorectal cancer progression |
| Q64082866 | Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair |
Search more.